GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
Authors
Keywords
-
Journal
BEHAVIOURAL BRAIN RESEARCH
Volume 445, Issue -, Pages 114386
Publisher
Elsevier BV
Online
2023-03-20
DOI
10.1016/j.bbr.2023.114386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
- (2021) Jonathan Flintoff et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Reduction in TNF alpha and oxidative stress by liraglutide: Impact on ketamine-induced cognitive dysfunction and hyperlocomotion in rats
- (2021) Amina Ahmed Sedky et al. LIFE SCIENCES
- The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder
- (2020) Adriano José Maia Chaves Filho et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The facilitating effect of MK-801 on inhibitory avoidance memory via mTOR signaling in the mouse hippocampus
- (2020) Ming-Heng Hsiung et al. BEHAVIOURAL BRAIN RESEARCH
- Tolerance develops toward GLP-1 receptor agonists’ glucose-lowering effect in mice
- (2020) Tuuli Sedman et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Quetiapine Attenuates Schizophrenia-Like Behaviors and Demyelination in a MK-801–Induced Mouse Model of Schizophrenia
- (2020) Jue He et al. Frontiers in Psychiatry
- The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis
- (2019) Wenhui Yan et al. LIFE SCIENCES
- Liraglutide Lowers Body Weight Set Point in DIO Rats and its Relationship with Hypothalamic Microglia Activation
- (2019) Ting Liao et al. Obesity
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats
- (2018) Ilijana Babic et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Liraglutide modulates gut microbiota and reduces NAFLD in obese mice
- (2018) GV Moreira et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties
- (2018) Alana Gomes de Souza et al. BIOMEDICINE & PHARMACOTHERAPY
- Liraglutide Activates mTORC1 Signaling and AMPA Receptors in Rat Hippocampal Neurons Under Toxic Conditions
- (2018) Sung Woo Park et al. Frontiers in Neuroscience
- ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway
- (2017) Mao-sheng Fang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Liraglutide reduces body weight by upregulation of adenylate cyclase 3
- (2017) Z Li et al. Nutrition & Diabetes
- Effect of Liraglutide on Corneal Kindling Epilepsy Induced Depression and Cognitive Impairment in Mice
- (2016) Prashant Koshal et al. NEUROCHEMICAL RESEARCH
- Exendin-4 antagonizes Aβ1-42-induced attenuation of spatial learning and memory ability
- (2016) Xiaohui Wang et al. Experimental and Therapeutic Medicine
- Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma
- (2016) Brian DellaValle et al. Frontiers in Pharmacology
- Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice
- (2015) Paula L. McClean et al. BEHAVIOURAL BRAIN RESEARCH
- Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer’s Disease and Other Neurodegenerative Diseases
- (2015) Valeria Calsolaro et al. CNS DRUGS
- Involvement of the CA1 GABAA receptors in MK-801-induced anxiolytic-like effects
- (2014) Mohammad-Hasan Naseri et al. BEHAVIOURAL PHARMACOLOGY
- Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
- (2013) Vadivel Parthsarathy et al. PLoS One
- Energy Intake and Exercise as Determinants of Brain Health and Vulnerability to Injury and Disease
- (2012) Mark P. Mattson Cell Metabolism
- Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice
- (2012) W D Porter et al. INTERNATIONAL JOURNAL OF OBESITY
- Neuroprotective actions of Glucagon-like peptide-1 in differentiated human neuroprogenitor cells
- (2012) Kalpana Velmurugan et al. JOURNAL OF NEUROCHEMISTRY
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Acute low dose of MK-801 prevents memory deficits without altering hippocampal DARPP-32 expression and BDNF levels in sepsis survivor rats
- (2010) Omar J. Cassol-Jr et al. JOURNAL OF NEUROIMMUNOLOGY
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
- (2009) Talib Abbas et al. BEHAVIOURAL BRAIN RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now